Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

Current list price: GLP-1 medications range from $855 to $1,349. ... approved to help lower blood sugar levels in people with type 2 diabetes. Ozempic and Wegovy are two different brands of the ...

The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors ... Mounjaro carries a list price of $1,086.37 for each fill "Mounjaro (tirzepatide) 2.5 mg, 5 mg, 7.5 mg ...

It's possible that Alzheimer's disease could be added to the lengthening list of health conditions that can be improved by treatment with GLP-1 receptor agonists. The phase 2 ELAD study of Novo ...

Sosei Heptares' longstanding alliance with Pfizer has advanced a first candidate into phase 2 testing ... drugs directed at G protein-coupled receptor (GPCR) targets since 2015. The GLP-1 agonist ...

GLP-1RA medications in preadolescents and adolescents were concentrated among those with diabetes, obesity, mood disorders, and anxiety.

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...